Call us + 1.800.210.5124
Multiple sclerosis (MS) is a nervous system disease that affects the brain and spinal cord. It damages the myelin sheath, the material that surrounds and protects the nerve cells. This damage slows down or blocks messages between brain and body, leading to the symptoms of MS.
World Stem Cells Clinic’s Advanced Stem Cell Therapy (ASCT) for MS
In World Stem Cells Clinic we treat MS in a different way form the standard approach, because instead of temporally masking the symptoms with drugs, our Advanced Stem Cell therapy is a drug-free treatment that use your body’s own repair and regeneration system to heal and slow the progression of the disease in order to get an overall better quality of life.
There’s a growing body of evidence that indicates that by changing the level of inflammation and modifying the immune function by our Stem Cells, the body starts to slow and reverse the demyelination process.
A study designed and conducted at World Stem Cells Clinic for MS, showed patients with documented significant changes in multiple areas of function, and improving in various symptoms like:
- Muscle spasms
- Balance problems and lack of coordination
- Difficulty moving arms and legs
- Unsteady gait and difficulty walking
- Weakness or tremor in one or both arms and legs
- Better overall quality of life
- Higher energy levels
News and references supporting our studies
A.S. Fassas, J. R. Passweg, A. Anagnostopoulos, A. Kazis, T. Kozak, E. Havrdova, E. Carreras, F. Graus, A. Kashyap, H. Openshaw, et al.. (July, 2002). Hematopoietic stem cell transplantation for multiple sclerosis. Journal of Neurology, 249, 1088-1097. 2014, From Springer Link Data Base
Mancardi G, Saccardi R. (2008). Autologous haematopoietic stem-cell transplantation in multiple sclerosis.. 2014, from NCBI Pub Med Web Site: http://www.ncbi.nlm.nih.gov/pubmed/18565456
Blanco Y, Saiz A, Carreras E, Graus F.. (2005). Autologous haematopoietic-stem-cell transplantation for multiple sclerosis.. 2013, From NCBI Pub Med Web Site: http://www.ncbi.nlm.nih.gov/pubmed/15620857
R. Saccardi, T. Kozak, C Bocelli-Tyndall, et al. (2012). Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party data